|
Roivant Sciences SHS
(ROIV)
|
6.0 |
$133M |
|
3.8M |
35.39 |
|
Apogee Therapeutics
(APGE)
|
5.9 |
$131M |
|
987k |
132.73 |
|
Spyre Therapeutics Com New
(SYRE)
|
5.1 |
$114M |
|
1.3M |
88.78 |
|
Xenon Pharmaceuticals
(XENE)
|
4.4 |
$96M |
|
1.6M |
60.36 |
|
Erasca
(ERAS)
|
4.3 |
$96M |
|
5.3M |
18.32 |
|
Alkermes SHS
(ALKS)
|
3.3 |
$72M |
|
1.4M |
52.40 |
|
Insmed Com Par $.01
(INSM)
|
3.1 |
$69M |
|
650k |
106.62 |
|
Moderna Put Option
(MRNA)
|
3.1 |
$68M |
|
975k |
70.03 |
|
Praxis Precision Medicines I Com New
(PRAX)
|
2.8 |
$62M |
|
185k |
334.79 |
|
Oruka Therapeutics
(ORKA)
|
2.5 |
$56M |
|
590k |
95.17 |
|
Anaptysbio Inc Common
(ANAB)
|
2.5 |
$56M |
|
826k |
67.50 |
|
Avalo Therapeutics Com New
(AVTX)
|
2.4 |
$54M |
|
2.9M |
18.48 |
|
Cytokinetics Com New
(CYTK)
|
2.1 |
$47M |
|
550k |
85.19 |
|
Revolution Medicines
(RVMD)
|
2.1 |
$47M |
|
250k |
187.28 |
|
Abivax Sa Sponsored Ads
(ABVX)
|
2.0 |
$44M |
|
330k |
133.26 |
|
First Tracks Biotherapeutics Ord Shs
(TRAX)
|
1.8 |
$41M |
|
2.0M |
20.12 |
|
Dianthus Therapeutics
(DNTH)
|
1.8 |
$39M |
|
400k |
97.48 |
|
Sutro Biopharma Com Shs
(STRO)
|
1.8 |
$39M |
|
1.2M |
33.20 |
|
Nuvalent Inc-a
(NUVL)
|
1.5 |
$34M |
|
275k |
123.50 |
|
Trevi Therapeutics
(TRVI)
|
1.5 |
$34M |
|
1.8M |
18.65 |
|
Ark Etf Tr Genomic Rev Etf Call Option
(ARKG)
|
1.4 |
$32M |
|
750k |
42.06 |
|
Ovid Therapeutics
(OVID)
|
1.2 |
$27M |
|
10M |
2.69 |
|
Lexeo Therapeutics
(LXEO)
|
1.2 |
$27M |
|
5.8M |
4.66 |
|
Celldex Therapeutics Com New
(CLDX)
|
1.2 |
$26M |
|
700k |
37.21 |
|
Belite Bio Sponsored Ads
(BLTE)
|
1.1 |
$25M |
|
165k |
153.99 |
|
Enliven Therapeutics
(ELVN)
|
1.1 |
$25M |
|
500k |
50.75 |
|
Forte Biosciences Com New
(FBRX)
|
1.1 |
$24M |
|
1.1M |
21.25 |
|
Eli Lilly & Co. Call Option
(LLY)
|
1.1 |
$24M |
|
20k |
1199.43 |
|
Nurix Therapeutics
(NRIX)
|
1.1 |
$24M |
|
968k |
24.26 |
|
Alto Neuroscience Com Shs
(ANRO)
|
1.0 |
$22M |
|
850k |
26.39 |
|
Madrigal Pharmaceuticals
(MDGL)
|
1.0 |
$22M |
|
40k |
536.95 |
|
Protagonist Therapeutics
(PTGX)
|
1.0 |
$21M |
|
172k |
122.58 |
|
Mineralys Therapeutics
(MLYS)
|
0.9 |
$20M |
|
750k |
26.98 |
|
Relay Therapeutics
(RLAY)
|
0.9 |
$20M |
|
1.1M |
18.71 |
|
Sagimet Biosciences Com Ser A
(SGMT)
|
0.9 |
$19M |
|
2.5M |
7.73 |
|
Jade Biosciences Com New
(JBIO)
|
0.8 |
$19M |
|
840k |
22.22 |
|
Cogent Biosciences
(COGT)
|
0.8 |
$17M |
|
450k |
38.70 |
|
Uniqure Nv SHS
(QURE)
|
0.8 |
$17M |
|
375k |
46.06 |
|
Travere Therapeutics
(TVTX)
|
0.8 |
$17M |
|
300k |
56.81 |
|
Cullinan Oncology
(CGEM)
|
0.7 |
$16M |
|
876k |
18.21 |
|
Savara
(SVRA)
|
0.7 |
$16M |
|
2.5M |
6.16 |
|
Ideaya Biosciences
(IDYA)
|
0.7 |
$15M |
|
400k |
37.27 |
|
Perspective Therapeutics Com New
(CATX)
|
0.6 |
$14M |
|
4.2M |
3.41 |
|
Odyssey Therapeutics Common Stock
|
0.6 |
$14M |
|
766k |
18.71 |
|
Cogent Biosciences Note 1.625%11/1 (Principal)
|
0.6 |
$14M |
|
11M |
1.24 |
|
Omeros Corporation Put Option
(OMER)
|
0.6 |
$13M |
|
1.4M |
9.51 |
|
Helix Acquisition Corp Iii Usd Cl A Ord Shs
(HLXC)
|
0.6 |
$13M |
|
1.3M |
10.64 |
|
Equillium
(EQ)
|
0.6 |
$13M |
|
4.1M |
3.20 |
|
Establishment Labs Holdings Ord
(ESTA)
|
0.6 |
$13M |
|
148k |
85.81 |
|
Eliem Therapeutics
(CLYM)
|
0.6 |
$13M |
|
972k |
13.04 |
|
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
0.6 |
$13M |
|
374k |
33.88 |
|
Veradermics Common Stock
(MANE)
|
0.6 |
$12M |
|
100k |
122.94 |
|
Arrowhead Pharmaceuticals
(ARWR)
|
0.6 |
$12M |
|
150k |
81.51 |
|
Omeros Corp Note 9.500% 6/1 (Principal)
|
0.6 |
$12M |
|
6.5M |
1.87 |
|
Taysha Gene Therapies Com Shs
(TSHA)
|
0.5 |
$12M |
|
1.8M |
6.81 |
|
Damora Therapeutics Com New
(DMRA)
|
0.5 |
$11M |
|
425k |
26.01 |
|
Eupraxia Pharmaceuticals
(EPRX)
|
0.5 |
$11M |
|
1.7M |
6.61 |
|
Vera Therapeutics Cl A
(VERA)
|
0.5 |
$11M |
|
250k |
42.91 |
|
Proqr Thrapeutics N V Shs Euro
(PRQR)
|
0.5 |
$10M |
|
5.5M |
1.86 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.4 |
$9.3M |
|
275k |
33.89 |
|
Korro Bio
(KRRO)
|
0.4 |
$9.3M |
|
707k |
13.18 |
|
Anteris Technologies Global
(AVR)
|
0.4 |
$9.0M |
|
912k |
9.85 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.4 |
$8.6M |
|
1.5M |
5.90 |
|
Ascendis Pharma A/s Ord Shs
(ASND)
|
0.4 |
$8.0M |
|
30k |
266.72 |
|
Ibio Com New
(IBIO)
|
0.3 |
$7.0M |
|
4.0M |
1.75 |
|
Generate Biomedicines Com Shs
(GENB)
|
0.3 |
$6.7M |
|
400k |
16.87 |
|
Evommune Com Shs Put Option
(EVMN)
|
0.3 |
$6.6M |
|
500k |
13.29 |
|
Tyra Biosciences
(TYRA)
|
0.3 |
$6.4M |
|
200k |
31.94 |
|
Sol-gel Technologies Shs New
(SLGL)
|
0.3 |
$6.3M |
|
85k |
74.14 |
|
Sab Biotherapeutics Com New
(SABS)
|
0.3 |
$5.9M |
|
1.5M |
3.90 |
|
Macrogenics
(MGNX)
|
0.3 |
$5.6M |
|
1.2M |
4.62 |
|
Crispr Therapeutics Namen Akt
(CRSP)
|
0.2 |
$5.5M |
|
100k |
54.54 |
|
Newamsterdam Pharma Company *w Exp 99/99/999
(NAMSW)
|
0.2 |
$5.3M |
|
245k |
21.81 |
|
Assembly Biosciences Com New
(ASMB)
|
0.2 |
$5.2M |
|
190k |
27.48 |
|
Rezolute Com New
(RZLT)
|
0.2 |
$5.2M |
|
1.0M |
5.20 |
|
Precision Biosciences Com New
(DTIL)
|
0.2 |
$5.1M |
|
647k |
7.86 |
|
Hemab Therapeutics Hldgs Com Shs
|
0.2 |
$5.1M |
|
138k |
36.73 |
|
Miragen Therapeutics
(VRDN)
|
0.2 |
$4.6M |
|
250k |
18.37 |
|
Arrivent Biopharma
(AVBP)
|
0.2 |
$4.3M |
|
125k |
34.74 |
|
Verrica Pharmaceuticals Com Shs
(VRCA)
|
0.2 |
$4.3M |
|
707k |
6.12 |
|
Compass Pathways Sponsored Ads
(CMPS)
|
0.2 |
$4.3M |
|
301k |
14.15 |
|
Mbx Biosciences
(MBX)
|
0.2 |
$4.1M |
|
75k |
55.20 |
|
Research Alliance Corp Iii Ord Shs Cl A
|
0.2 |
$4.0M |
|
370k |
10.70 |
|
Immunovant
(IMVT)
|
0.2 |
$3.9M |
|
100k |
38.53 |
|
Amanat Acquisition Corp Cl A Ord
|
0.2 |
$3.8M |
|
375k |
10.16 |
|
Biohaven
(BHVN)
|
0.2 |
$3.7M |
|
250k |
14.88 |
|
Faeth Therapeutics Com New
(FTH)
|
0.2 |
$3.6M |
|
144k |
25.00 |
|
Karyopharm Therapeutics Com New
(KPTI)
|
0.1 |
$3.1M |
|
313k |
9.77 |
|
Alector
(ALEC)
|
0.1 |
$3.0M |
|
1.5M |
2.01 |
|
Spyglass Pharma Com Shs
(SGP)
|
0.1 |
$2.9M |
|
132k |
22.26 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
0.1 |
$2.8M |
|
75k |
37.42 |
|
Oaktree Acquisition Corp Iii Unit 10/04/2029
(OACCU)
|
0.1 |
$2.8M |
|
250k |
11.00 |
|
Celcuity Note 0.250% 8/0 (Principal)
|
0.1 |
$2.3M |
|
2.0M |
1.14 |
|
Jatt Ii Acquisition Corp Ord Shs
|
0.1 |
$2.3M |
|
200k |
11.36 |
|
Neumora Therapeutics
(NMRA)
|
0.1 |
$1.8M |
|
1.1M |
1.70 |
|
Amylyx Pharmaceuticals
(AMLX)
|
0.1 |
$1.8M |
|
99k |
17.96 |
|
Adlai Nortye Sponsored Ads
(ANL)
|
0.1 |
$1.8M |
|
154k |
11.50 |
|
Spruce Biosciences Com New
(SPRB)
|
0.1 |
$1.6M |
|
30k |
54.00 |
|
Summit Therapeutics Call Option
(SMMT)
|
0.1 |
$1.5M |
|
100k |
14.57 |
|
Eikon Therapeutics
(EIKN)
|
0.1 |
$1.3M |
|
98k |
13.05 |
|
Onkure Therapeutics Com Cl A
(OKUR)
|
0.0 |
$1.1M |
|
241k |
4.56 |
|
Engene Therapeutics
(ENGN)
|
0.0 |
$1.0M |
|
600k |
1.73 |
|
X4 Pharmaceuticals Com New
(XFOR)
|
0.0 |
$677k |
|
145k |
4.67 |
|
Boundless Bio
(BOLD)
|
0.0 |
$625k |
|
250k |
2.50 |
|
Lenz Therapeutics
(LENZ)
|
0.0 |
$568k |
|
100k |
5.68 |
|
Q32 Bio
(QTTB)
|
0.0 |
$354k |
|
28k |
12.74 |
|
Health Sciences Acq Corp 2
(OBIO)
|
0.0 |
$144k |
|
33k |
4.32 |
|
Nextcure Com New
(NXTC)
|
0.0 |
$67k |
|
42k |
1.60 |
|
Adagio Med Hldgs
(ADGM)
|
0.0 |
$52k |
|
80k |
0.65 |
|
Rocket Pharmaceuticals *w Exp 09/02/202
(RCKTW)
|
0.0 |
$277.500000 |
|
75k |
0.00 |